Pharma companies are creating vaccines like they’re candy! They have now released over 270 new vaccines, and each with their own individual toxins, chemicals, and side effects.
The most controversial vaccine so far, the flu shot, has been linked to causing autism in over 22 different studies. The flu shot isn’t the only one either. Another study published in the Journal Annals of Epidemiology showed that giving the hepatitis B vaccine to newborn baby males could triple their risk of developing autism spectrum disorder! The research was conducted at Stony Brook University Medical Center in New York. It seems as if the vaccines they have unveiled upon us time after time does very little good. In fact, some vaccines have even worsened or increased people’s chances of contracting the said disease.
With vaccines causing more and more adverse effects, you would expect to see a little bit of reform in this area, but there has never been. “No vaccine manufacturer shall be liable…for damages arising from a vaccine-related injury or death.” – President Ronald Wilson Reagan, as he signed The National Childhood Vaccine Injury Act (NCVIA).
The NCVIA relinquished vaccine manufacturers of their legal responsibilities for death or injury caused by the vaccines THEY created. It is important for every individual’s health to refrain from these toxic pharmaceutical products. We can expect to see more and more unveiled and marketed to us.
PhRMA (the Pharmaceutical Research and Manufacturers of America) states, “today, more than 7,000 medicines are in development globally, all of which have the potential to help patients in the United States and around the world. According to another data source, there are 3,400 medicines in development today just in the United States, an increase of 40 percent since 2005.”
They also claim that they will be the solution to hundreds of infectious diseases, including cancer. They said, “”the 271 vaccines in development span a wide array of diseases, and employ exciting new scientific strategies and technologies. These potential vaccines – all in human clinical trials or under review by the Food and Drug Administration (FDA) – include 137 for infectious diseases, 99 for cancer, 15 for allergies and 10 for neurological disorders.”
Here is a list of 146 of the 271 vaccines in the Pharma’s Development Pipeline since 2010:
- sanofi pasteur prevention of Clostridium difficile
- ACE BioSciences prevention of traveler’s diarrhea caused by Campylobacter jejuni
- ACE BioSciences prevention of traveler’s diarrhea caused by Escherichia coli
- sanofi pasteur diphtheria, tetanus, pertussis Phase III DTP vaccine
- Aeras Global tuberculosis
- Novartis Vaccines prevention of influenza A infection (H5N1 subtype)
- Antigenics treatment of herpes simplex virus
- BioSante Pharmaceuticals anthrax Phase I/II vaccine
- Intercell USA anthrax
- KaloBios Pharmaceuticals Pseudomonas aeruginosa infections
- Aduro BioTech treatment of hepatitis C
- Emergent BioSolutions anthrax vaccine
- AlphaVax prevention of influenza virus infections in the elderly
- DynPort Vaccine botulism vaccine
- Inviragen Chikungunya virus vaccine
- Celldex Therapeutics cholera vaccine (live attenuated)
- ChronTech Pharma hepatitis C (DNA vaccine)
- Virionics prevention and treatment of hepatitis C
- Vical prevention of cytomegalovirus (DNA vaccine)
- AlphaVax prevention of cytomegalovirus infections
- Hawaii Biotech prevention of dengue fever
- GlaxoSmithKline prevention of dengue fever (tetravalent)
- Acambis mild to severe dengue fever
- sanofi pasteur DTP-Hep B
- sanofi pasteur diphtheria, tetanus, pertussis, polio, hepatitis B, polio, Hib
- Dynavax treatment of hepatitis B
- Crucell prevention of Ebola virus infections
- Vical prevention of Ebola virus infections
- GenPhar Ebola virus vaccine
- GlaxoSmithKline prevention of infectious mononucleosis (Epstein-Barr virus)
- BioSolutions Escherichia coli infections
- Celldex Therapeutics prevention of cholera, Escherichia coli infections
- Protein Sciences prevention of influenza virus infections in adults and children
- sanofi pasteur influenza virus infections (new mass production method)
- sanofi pasteur prevention of influenza virus (intradermal micro-injection)
- Protein Sciences influenza virus infections
- GlaxoSmithKline rotavirus infections in infants
- GlaxoSmithKline prevention of cytomegalovirus (recombinant vaccine)
- GlaxoSmithKline influenza virus (trivalent, thimerosal-free) for children ages 3-17
- GlaxoSmithKline prevention of influenza virus
- GlaxoSmithKline prevention of Streptococcus pneumoniae
- GlaxoSmithKline prevention of diphtheria, tetanus, pertussis, Haemophilus infections, hepatitis B, meningococcal group C infections, poliomyelitis (infants)
- GlaxoSmithKline prevention of Haemophilus and pneumococcal infections
- GlaxoSmithKline prevention of Haemophilus and pneumococcal infections
- GlaxoSmithKline prevention of influenza virus infection in children
- GlaxoSmithKline prevention of influenza A virus (H1N1 subtype) for children and infants
- GlaxoSmithKline staphylococcal infections
- MedImmune influenza A virus (H5N1 subtype) intranasal
- Novavax prevention of influenza A virus infection
- Hawaii Biotech prevention of West Nile virus infection
- Novartis Vaccines helicobacter pylori
- Pfizer hepatitis B (DNA)
- Emergent BioSolutions hepatitis B
- GenPhar hepatitis B
- Novartis Vaccines treatment of hepatitis C
- GlaxoSmithKline hepatitis E (recombinant)
- Dynavax prevention of hepatitis B
- Pfizer treatment of herpes simplex virus infections (DNA vaccine)
- AuRx prevention and treatment of herpes simplex virus infections
- sanofi pasteur diphtheria, tetanus, pertussis, hepatitis B, polio, Hib
- Intercell prevention of influenza virus seasonal influenza
- Novartis Vaccines prevention of herpes simplex virus infections
- Acambis prevention of encephalitis virus
- Bavarian Nordic smallpox vaccine
- sanofi pasteur influenza A virus (H1N1 subtype) in adolescents, children and infants
- CSL Behring prevention of influenza A virus (H1N1 subtype) for the elderly
- Baxter Healthcare prevention of influenza A virus (H1N1 subtype)
- Vical prevention of influenza A virus (DNA – H1N1 subtype)
- Baxter Healthcare prevention of influenza A virus (H5N1 subtype)
- DynPort Vaccine influenza virus
- Antigen Express influenza virus infections H5N1 vaccine
- Novavax prevention of influenza virus (particle vaccine)
- Dynavax prevention of influenza virus infections
- Vaxin influenza virus infections (intranasal)
- Abbott Laboratories prevention of influenza virus (cell culture-derived)
- Intercell prevention of Japanese encephalitis in children
- Novartis Vaccines malaria vaccine (U.S. Naval Medical Research Center)
- Vical malaria vaccine
- BioSante Pharmaceuticals prevention of malaria (U.S. Naval Medical Research Center)
- GenVec malaria vaccine (U.S. Naval Medical Research Center)
- Crucell malaria vaccine
- Sanaria malaria vaccine
- GenPhar Marburg virus (DNA vaccine)
- MedImmune parainfluenza virus infections in children and infants
- MedImmune prevention of respiratory syncytial virus infections in infants
- MedImmune prevention of parainfluenza virus infections in children and infants
- MedImmune prevention of influenza virus (quadrivalent) for adolescents and children
- sanofi pasteur Neisseria meningitidis A, C in toddlers 9 months-12 months
- GlaxoSmithKline prevention of Neisseria meningitidis groups C and Y, Haemophilus influenzae type B, and tetanus toxoid
- sanofi pasteur meningitis in infants
- Novartis Vaccines meningococcal group B infections vaccine group B
- Novartis Vaccines meningococcal group A, C infections in children
- Novartis Vaccines meningococcal group A, C infections in infants
- GlaxoSmithKline prevention of malaria (recombinant vaccine)
- NanoBio prevention of influenza virus (intranasal)
- GlaxoSmithKline prevention of influenza virus inactivated split-trivalent vaccine
- GlaxoSmithKline prevention of Neisseria meningitidis groups A, C in children
- LigoCyte Pharmaceuticals norovirus infections (intranasal)
- Novartis Vaccines prevention of influenza virus
- Protein Sciences prevention of influenza A pandemic (H5N1 subtype)
- Meridian Biosciences parvovirus infections
- Crucell prevention of influenza virus infections
- Pfizer meningococcal group B infections (meningococcal “plague” vaccine)
- DynPort Vaccine Yersinia infections (injectable)
- Baxter Healthcare prevention of seasonal influenza virus
- GlaxoSmithKline prevention of influenza A virus (“pre-pandemic”)
- Pfizer prevention of pneumococcal infection in the elderly (Prevnar 13 Adult™)
- sanofi pasteur rabies vaccine
- BioSante Pharmaceuticals ricin poisoning (“biodefense” vaccine)
- Soligenix ricin poisoning
- sanofi pasteur prevention of rotavirus infections
- Bharat Biotech prevention of rotavirus infections
- Emergent BioSolutions anthrax (Fast Track) “protective antigen” vaccine
- Inhibitex staphylococcal infections
- Vical prevention of severe acute respiratory syndrome (SARS) coronavirus infections
- Emergent BioSolutions shigella infections
- GlaxoSmithKline prevention of herpes simplex virus infections
- PharmAthene anthrax (“protective antigen” – rPA)
- BioSante Pharmaceuticals staphylococcal infections (“biodefense” vaccine)
- Nabi Biopharmaceutical prevention of staphylococcal aureus infections
- GlaxoSmithKline prevention of staphylococcal aureus infections
- Nabi Biopharmaceutical prevention of streptococcal B infections
- Emergent BioSolutions prevention of streptococcal infections
- Novartis Vaccines prevention of streptococcal infections
- sanofi pasteur prevention of meningitis and pneumonia (tetravalent)
- Inviragen treatment of dengue fever
- Intercell USA prevention of traveler’s diarrhea due to E. coli (“patch” technology)
- GlaxoSmithKline tuberculosis
- Aerus Global TB prevention of tuberculosis in young children
- GlaxoSmithKline prevention of tuberculosis in adults
- sanofi pasteur prevention of tuberculosis
- DynPort Vaccine tularemia
- Emergent BioSolutions prevention of typhoid (live typhoid organisms – oral vaccine)
- Novartis Vaccines prevention of typhoid fever
- Celldex Therapeutics typhoid fever
- Merck prevention of herpes zoster (shingles)
- Merck hepatitis B in infants
- Merck human papillomavirus infections
- Merck staphylococcal infections
- GlaxoSmithKline prevention of varicella zoster virus
- VaxInnate prevention of influenza A virus
- VaxInnate influenza A virus infections in elderly patients
- VaxInnate prevention of influenza A virus (H1N1 subtype)
- Inovio Pharmaceuticals human papillomavirus infections
- Inovio Pharmaceuticals prevention of influenza A virus (H5N1 subtype)
- Xcellerex prevention of yellow fever